Cost-Effectiveness of Switching to the Nonavale...

By Rene Pretorius

January 13, 2025

A recent study on the cost-effectiveness of transitioning from the bivalent human papillomavirus vaccine (2vHPV) to the nonavalent vacci...
GLP-1 Receptor Agonists: Balancing Benefits and Risks in Treatment Decisions
Valuable, Cost-Effective Thyroid Cancer Diagnosis
Cultural Challenges Hindering AI in Maternal Healthcare in Africa
Advancing Newborn Screening for Sickle Cell Disease in Africa
Abu Dhabi Introduces WINREVAIR: A Major Breakthrough in Pulmonary Arterial Hy...
Africa’s Health Crisis: Antimicrobial Resistance and Mpox Outbreak
Lenacapavir Injection: A Breakthrough in Global HIV Prevention
Transforming Cancer Care in Abu Dhabi
Reevaluating NICE’s Cost-Effectiveness Thresholds: The QALY Debate
Improving Access to Trikafta for Cystic Fibrosis Patients in South Africa
Egypt’s Hepatitis C Program: A Model for Africa’s Health Initiatives
Maturity Level 3 in Medicines Regulation in Senegal and Rwanda